Pathologic staging of prostate carcinoma: What are the issues?

Cancer

Volumn 78, Issue 2, 1996, Pages 337-340

  Grignon, David J ^a   Sakr, Wael A ^b  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

cancer; prostate; stage; TNM

Indexed keywords

CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY;

CARCINOMA; FORECASTING; HUMANS; MALE; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0029682313     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960715)78:2<337::AID-CNCR23>3.0.CO;2-W     Document Type: Conference Paper

References (29)

1. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993;71:3582-93.
2. Bostwick DG, Myers RP, Oesterling JE. Staging of prostate cancer. Semin Surg Oncol 1994;10:60-72.
3. Ravery V, Boccon-Gibod LA, Meulemans A, Dauge-Geffroy MC, Toublanc M, Boccon-Gibod L. Predictive value of pathological features for progression after radical prostatectomy. Eur Urol 1994;26:197-201.
4. Schroder FH, Hermanek P, Fair WE. The TNM classification of prostate cancer. Prostate 1992;4:129-138.
5. American Joint Committee on Cancer. Manual for Staging of Cancer. Philadelphia: Lipincott, 1992.
6. Montie JE. Staging of prostate cancer. Current TNM classification and future prospects for prognostic factors. Cancer 1995;75:1814-18.
7. The British Association of Urologic Surgeons TNM Subcommittee. The TNM classification of prostate cancer. A discussion of the 1992 classification. Br J Urol 1995;76:279-85.
8. Foucar E, Haake G, Dalton L, Pathak DR, Lujan JP. The area of cancer in transurethral resection specimens as a prognostic indicator in carcinoma of the prostate. A computer assisted morphometric study. Hum Pathol 1993;21:586-92.
9. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271:368-74.
10. Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995;154:1818-24.
11. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, Billebaud T, Delmas V, Meulemans A, et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology 1994;44:371-6.
12. Terris MK, Haney DJ, Johnstone IM, McNeal JE, Stamey TA. Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology 1995;45:75-80.
13. Peller PA, Young DC, Marmaduke DP, Marsh WL, Badalament RA. Sextant prostate biopsies: a histopathologic correlation with radical prostatectomy specimens. Cancer 1995; 75:530-8.
14. Bostwick DG, Qian J, Bergstralh E, Dundore P, Dugan J, Myers RP, et al. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996. In press.
15. McNeal JE. Anatomy of the prostate: a historical survey of divergent views. Prostate 1980;1:3-13.
16. Hall GS, Kramer CE, Epstein JI. Evaluation of radical prostatectomy specimens: a comparative analysis of sampling methods. Am J Surg Pathol 1992;16:315-24.
17. Sakr WA, Grignon DJ, Visscher DW, Wolman SR, Crissman JD. Evaluating the radical prostatectomy specimen: a protocol for establishing prognostic parameters and harvesting fresh tissue samples. J Urol Pathol 1995;3:355-64.
18. Villers A, McNeal JE, Freiha FS, Stamey TA. Multiple cancers in the prostate. Cancer 1992;70:2313-8.
19. Aihara M, Wheeler TM, Ohori M, Scardino PT. Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology 1994;43:60-6.
20. McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 1992;23:258-66.
21. Bostwick DG, Graham SD Jr., Napalkov P, Abrahamsson P-A, Di Sant'agnese AP, Fernando A, et al. Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 1993;41:403-11.
22. Greene DR, Wheeler TM, Egawa S, Dunn KJ, Scardino PT. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 1991;146:1069-76.
23. Villers A, McNeal JE, Freiha FS, Stamey TA. Multiple cancers in the prostate. Cancer 1992;70:2313-8.
24. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995;55:5408-13.
25. Ayala AG, Ro JY, Babaian RJ, Troncoso P, Grignon DJ. The prostatic capsule: does it exist? Am J Surg Pathol 1989;13:21-7.
26. Epstein JI, Carmichael MJ, Pizov G, Walsh PC. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol 1993;150:135-41.
27. Association of Directors of Anatomic and Surgical Pathology: recommendations for the reporting of resected prostate carcinomas. Hum Pathol 1996;27:321-3.
28. Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 1993;17:1252-61.
29. Weldon VE, Tavel FR, Neuwirth H, Cohen R. Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy. J Urol 1995; 153:1565-9.